Search

Your search keyword '"Nia, Amir M."' showing total 132 results

Search Constraints

Start Over You searched for: Author "Nia, Amir M." Remove constraint Author: "Nia, Amir M."
132 results on '"Nia, Amir M."'

Search Results

3. Randomized Control of Sympathetic Drive With Continuous Intravenous Esmolol in Patients With Acute ST-Segment Elevation Myocardial Infarction: The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial

5. Clinical Frailty Scale (CFS) reliably stratifies octogenarians in German ICUs: a multicentre prospective cohort study

9. The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (≥ 80 years)

16. A comparison of very old patients admitted to intensive care unit after acute versus elective surgery or intervention

19. Clinical Frailty Scale (CFS) reliably stratifies octogenarians in German ICUs : a multicentre prospective cohort study

21. Esmolol for tight heart rate control in patients with STEMI: Design and rationale of the beta-blocker in acute myocardial infarction (BEAT-AMI) trial

22. Esmolol for tight heart rate control in patients with STEMI: Design and rationale of the beta-blocker in acute myocardial infarction (BEAT-AMI) trial

24. Hot spots

25. Remote Ischemic Preconditioning and Renoprotection: From Myth to a Novel Therapeutic Option?

27. Accuracy of Doppler-Echocardiographic Mean Pulmonary Artery Pressure for Diagnosis of Pulmonary Hypertension

28. Hot spots

29. Response to Letter Regarding Article, “Ischemic Preconditioning for Prevention of Contrast Medium–Induced Nephropathy: Randomized Pilot RenPro-Trial (Renal Protection Trial)”

40. Beta1-Adrenoceptor Polymorphism Predicts Flecainide Action in Patients with Atrial Fibrillation.

42. Randomized Control of Sympathetic Drive With Continuous Intravenous Esmolol in Patients With Acute ST-Segment Elevation Myocardial Infarction The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial

46. Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unit

47. Lipid lowering therapy in cardiovascular disease: From myth to molecular reality.

48. [Oro- and nasopharyngeal swab for detection of SARS-CoV-2 - step-by-step approach].

49. [88-Year-Old Patient with Known Dementia and Progressive Vigilance Reduction].

Catalog

Books, media, physical & digital resources